Skip to main content
Caplight Logo









Hangzhou Artery Technology Co., Ltd.

Hangzhou Artery Technology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://www.arterytech.com/

Last Round

IPO

Jan 29, 2026

Company Overview

Hangzhou Artery Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. It was founded in 2018.

Hangzhou Artery Technology Co., Ltd. is a medical technology company that specializes in high-performance computing for medical imaging and AI-driven diagnostic solutions for cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hangzhou Artery Technology Co., Ltd. Comparables

Compare Hangzhou Artery Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Artery Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Raysight Medical
87%
Shukun Technology
86%
Shanghai United Imaging Healthcare
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hangzhou Artery Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJan 29, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hangzhou Artery Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou Artery Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hangzhou Artery Technology Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou Artery Technology Co., Ltd. a public or private company?

Hangzhou Artery Technology Co., Ltd. is a private company.

What is the current stock price of Hangzhou Artery Technology Co., Ltd.?

Hangzhou Artery Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Artery Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hangzhou Artery Technology Co., Ltd. worth (valuation)?

Valuation information for Hangzhou Artery Technology Co., Ltd. is not publicly available.

Can I buy Hangzhou Artery Technology Co., Ltd. stock?

Hangzhou Artery Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hangzhou Artery Technology Co., Ltd.'s last funding round?

Hangzhou Artery Technology Co., Ltd.'s most recent funding round was IPO on January 29, 2026.

Who are the main investors in Hangzhou Artery Technology Co., Ltd.?

Investor information for Hangzhou Artery Technology Co., Ltd. is not publicly disclosed.

Will Hangzhou Artery Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou Artery Technology Co., Ltd..

How can I track Hangzhou Artery Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Hangzhou Artery Technology Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersHangzhou
Year Founded2018
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?